TAK-779 Catalog No.:M10030-2 Pharmacokinetics and pharmacodynamics of PF-05231023
Pay in 4 interest-free payments of $26.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Live Spec
TAK-779 Catalog No.:M10030-2 Pharmacokinetics and pharmacodynamics of PF-05231023TAK 779 is a C C chemokine receptor type 5 (CCR5) receptor antagonist potentially for the treatment of HIV infection. Treatment with TAK 779 reduced incidence and severity of experimental autoimmune encephalomyelitis. It strongly inhibited migration of CXCR3 CCR5 bearing CD4+, CD8+ and CD11b+ leukocytes to the CNS. TAK 779 did not reduce proliferation of anti myelin oligodendrocyte glycoprotein T cells, the production of IFN gamma by T cells or CXCR3
Store: www.ab-travaux.com · Domain: www.ab-travaux.com

























